rs72547516 — CYP1A2 Ile386Val

CYP1A2 Ile386Val — A Rare Variant Affecting Drug and Caffeine Metabolism

CYP1A2 is one of the most abundant drug-metabolizing enzymes in the liver, responsible for breaking down approximately 10–15% of clinically used medications, including caffeine¹¹ caffeine
CYP1A2 processes ~95% of ingested caffeine, clozapine (antipsychotic), theophylline (asthma), olanzapine, tizanidine, and melatonin. The rs72547516 variant causes an isoleucine-to-valine substitution at position 386 of the CYP1A2 protein (p.Ile386Val), a missense change that may alter enzyme structure and reduce its metabolic capacity.

The Mechanism

The isoleucine at codon 386 sits within the substrate-binding region of CYP1A2. The Ile386Val substitution²² Ile386Val substitution
Valine's smaller side chain and slightly different steric profile may reduce the precision of substrate positioning or alter active-site geometry, affecting catalytic efficiency is predicted to reduce enzyme activity, though in-vivo data in large populations are lacking due to the variant's rarity. CYP1A2 is also highly inducible: cigarette smoke, charcoal-grilled meat, and cruciferous vegetables upregulate its expression via the aryl hydrocarbon receptor (AhR) pathway. Carriers of the G allele who are non-smokers would be expected to have reduced basal CYP1A2 activity, with limited compensatory induction.

The Evidence

This variant is extremely rare globally³³ extremely rare globally
G allele frequency 0.04–0.07% across major population databases; homozygous GG genotype essentially unobserved in population studies, with the highest observed frequencies in small Northern European cohorts (up to ~0.7% in Finnish samples and 2.5% in a small Danish sample). No ClinVar entry exists, and no CPIC or DPWG clinical guideline specifically addresses this variant.

The broader pharmacogenomics context is well-established: reduced CYP1A2 function, from any cause, leads to slower clearance of CYP1A2 substrates. A pathway-targeted pharmacogenomics study of 150 human liver samples⁴⁴ pathway-targeted pharmacogenomics study of 150 human liver samples
Klein K et al. Frontiers in Pharmacology, 2010 showed that genetic and environmental factors together explain about 42% of CYP1A2 activity variation, with both cis and trans regulatory polymorphisms contributing. Missense variants that alter active-site residues are classified as potentially impacting enzyme function in this framework.

The clinical relevance of CYP1A2 metabolizer status was demonstrated for caffeine and cardiovascular risk: Cornelis et al. (JAMA, 2006)⁵⁵ Cornelis et al. (JAMA, 2006)
Cornelis MC et al. Coffee, CYP1A2 Genotype, and Risk of Myocardial Infarction. JAMA, 2006 showed that slow metabolizers consuming 4+ cups of coffee daily had a 64% increased myocardial infarction risk (OR 1.64, 95% CI 1.14–2.34). For medications, CYP1A2 metabolizer status matters most for narrow-therapeutic-index drugs like clozapine and theophylline, where even a 30–50% reduction in clearance can push plasma concentrations into toxic ranges.

Practical Actions

If you carry the G allele (AG genotype), your CYP1A2 activity may be somewhat reduced compared to the AA majority. The most actionable steps involve monitoring drugs with narrow therapeutic windows, limiting caffeine especially if combining it with CYP1A2-inhibiting substances, and informing prescribers of your genotype before starting clozapine or theophylline.

CYP1A2 activity is strongly modifiable by lifestyle: smokers have 2–3× higher CYP1A2 induction, while cruciferous vegetables (broccoli, cabbage, Brussels sprouts) cause moderate induction. If you stop smoking, expect CYP1A2 activity to fall over several days, potentially raising levels of any CYP1A2-metabolized medications to clinical significance.

Interactions

The Ile386Val variant interacts with the well-characterized CYP1A2 inducibility variant rs762551 (*1F). Carriers of both the rs762551 slow-metabolizer C allele and this rs72547516 G allele could carry a compounded reduction in CYP1A2 baseline activity and inducibility, though this combination is expected to be vanishingly rare given the frequency of each allele. Smoking status is a major environmental modifier for both variants.